Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma
- Orlowski, R.Z.
- Nagler, A.
- Sonneveld, P.
- Bladé, J.
- Hajek, R.
- Spencer, A.
- Robak, T.
- Dmoszynska, A.
- Horvath, N.
- Spicka, I.
- Sutherland, H.J.
- Suvorov, A.N.
- Xiu, L.
- Cakana, A.
- Parekh, T.
- San-Miguel, J.F.
ISSN: 1097-0142, 0008-543X
Datum der Publikation: 2016
Ausgabe: 122
Nummer: 13
Seiten: 2050-2056
Art: Artikel